Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trialPedro M. Folegatti, Alexander Batten, Stephan Becker et al.|The Lancet|2020Cited by 2.6k
Human cytomegalovirus exploits STING signaling and counteracts IFN/ISG induction to facilitate infection of dendritic cellsBibiana Costa, Ulrich Kalinke, Stephan Becker et al.|Nature Communications|2024Cited by 22